DURASERT E
LIVE
Serial Number
98677791
Owner
EyePoint Pharmaceuticals US, Inc.Attorney
Shima RoyFiling Date
Aug 1, 2024
DURASERT E Trademark
Serial Number: 98677791
DURASERT E is a trademark filed by
EyePoint Pharmaceuticals US, Inc.
on August 1, 2024. The trademark is classified under Class 10 (Medical Apparatus).
The application is currently pending registration.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Shima Roy BAKER & MCKENZIE LLP
300 E. Randolph Street
Suite 5000
Chicago, IL 60601
United States
Trademark Details
Filing Date
August 1, 2024
Registration Date
Not Registered
Goods & Services
Injectable sustained drug delivery systems consisting of a bioerodible matrix for delivering pharmaceuticals via injection into the posterior segment of the eye
Filing History
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jun 2, 2026 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 2, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 2, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 2, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 2, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 2, 2026 COAR
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jun 2, 2026 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jun 2, 2026 GNSI
SUSPENSION INQUIRY WRITTEN
Jun 2, 2026 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 4, 2026 RCCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 11, 2026 ASGN
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 25, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 25, 2025 GNSL
SUSPENSION LETTER WRITTEN
Aug 25, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 21, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 21, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 21, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 6, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 6, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 8, 2025 GNRN
NON-FINAL ACTION E-MAILED
Feb 8, 2025 GNRT
NON-FINAL ACTION WRITTEN
Feb 8, 2025 CNRT
ASSIGNED TO EXAMINER
Feb 7, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 16, 2025 NWOS
NEW APPLICATION ENTERED
Aug 1, 2024 NWAP
